Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Recruiting 2Completed 2Active not recruiting 2Unknown 1Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1Plasma cell 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Glioblastoma 1Drug Resistant Epilepsy 1Brain Neoplasms 1Autism Spectrum Disorder 1

Interventions

Temozolomide 79Magnetic Resonance Spectroscopy 69Specimen Handling 45Radiotherapy 42Bevacizumab 29Radiosurgery 27Cyclophosphamide 27Radiation 20pembrolizumab 19Blood Specimen Collection 19fludarabine 16Nivolumab 16Irinotecan 15Carboplatin 13Biopsy 13Etoposide 12Vincristine 11Pemetrexed 11Lomustine 11dinutuximab 9Surgical Procedures, Operative 9trametinib 8abemaciclib 8Ipilimumab 8Fluorodeoxyglucose F18 8naxitamab 7fluciclovine F-18 7Watchful Waiting 7Topotecan 7Proton Therapy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Diet, Ketogenic × CNS × Clear all
NCT05708352 2026-05-06

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

Cedars-Sinai Medical Center

Phase 2 Recruiting
170 enrolled
CNS

Glioblastoma

NCT06309251 2025-09-03

Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients

Danone Nutricia SpA Società Benefit

Recruiting
100 enrolled
CNS

Autism Spectrum Disorder, Drug Resistant Epilepsy, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡